Humana (HUM) Asset Writedowns and Impairment (2022 - 2026)

Humana's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment fell 77.78% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $21.0 million (down 89.95% YoY), while the FY2025 annual figure was $28.0 million, down 86.0% from the prior year.
• Asset Writedowns and Impairment was $2.0 million for Q1 2026 at Humana, up from -$4.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $200.0 million in Q4 2024 to a low of -$144.0 million in Q4 2022.
• Historically, Asset Writedowns and Impairment has averaged $19.5 million across 5 years, with a median of $9.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment surged 675.0% in 2023, then slumped 102.0% in 2025.
• A 5-year view of Asset Writedowns and Impairment shows it stood at -$144.0 million in 2022, then surged by 141.67% to $60.0 million in 2023, then jumped by 233.33% to $200.0 million in 2024, then plunged by 102.0% to -$4.0 million in 2025, then jumped by 150.0% to $2.0 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $2.0 million (Q1 2026), -$4.0 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.